Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort study
利妥昔单抗一线治疗与艾曲波帕单药治疗一线治疗后儿童持续性/慢性免疫难治性血小板减少症的疗效比较:一项前瞻性多中心队列研究
期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2025.103241
Ma, Jingyao; Wang, Zhifa; Ouyang, Juntao; Lin, Zheyan; Fu, Lingling; Chen, Zhenping; Liu, Yan; Wang, Lijuan; Lin, Xi; Cheng, Xiaoling; Hu, Yu; Dong, Shuyue; Meng, Jinxi; Ma, Jie; Wu, Runhui